Peregrine Pharmaceuticals (NASDAQ:PPHM), a biopharmaceutical company committed to improving patient lives by manufacturing high quality products for biotechnology and pharmaceutical companies and advancing …
Peregrine Pharmaceuticals (NASDAQ:PPHM) announced that top-line data from the Phase III SUNRISE trial of bavituximab in patients with previously treated locally advanced or …
Yesterday, Peregrine Pharmaceuticals (NASDAQ:PPHM) hosted a conference call to discuss its financial first quarter results for 2017, with the three-month quarter having ended …
Peregrine Pharmaceuticals (NASDAQ:PPHM), a biopharmaceutical company committed to improving patient lives by manufacturing high quality products for biotechnology and pharmaceutical companies and advancing its …
Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM), a biopharmaceutical company committed to improving patient lives by manufacturing high quality products for biotechnology and pharmaceutical companies and advancing …
Roth Capital analyst Joseph Pantginis was out today with a research note on Peregrine Pharmaceuticals (NASDAQ:PPHM), after the drug-maker announced financial results for the fourth …
Peregrine Pharmaceuticals (NASDAQ:PPHM), a biopharmaceutical company committed to improving patient lives by delivering high quality biological products through its contract development and manufacturing organization …
Peregrine Pharmaceuticals (NASDAQ:PPHM), a biopharmaceutical company committed to improving patient lives by delivering high quality biological products through its contract development and manufacturing …
Galena Biopharma Inc FBR analyst Vernon Bernardino weighs in on Galena Biopharma Inc (NASDAQ:GALE), after the biotech company announced that the FDA has given Fast …
In a research report issued Friday, FBR analyst Thomas Yip reiterated an Outperform rating on shares of Peregrine Pharmaceuticals (NASDAQ:PPHM), with a $1.00 price target, …
